Direkt zum Inhalt

Order

page banner image

Main Details:

Case number
UPC_CFI_1/2023
Date
Parties
Amgen, Inc.
v.
Sanofi-Aventis Deutschland GmbH
Order/Decision reference
ORD_550152/2023
Type of action(s)
Revocation action
Language of Proceedings
English
Court - Division
Court of First Instance - Munich (DE) Central Division - Section

Headnotes:

Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. The wish from a natural person to form an opinion on the validity of a patent out of a personal and a professional interest is not a legitimate reason as required by Rule 262.1(b) RoP.

Schlüsselwörter:

Rule 262.1(b) RoP request (rejected). Legitimate reason for access (no).